Methodological Challenges in Biomedical HIV Prevention Trials (2008)

Chapter: 4 Design Considerations: Pregnancy

Previous Chapter: 3 Design Considerations: Risk-Reduction Counseling
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 104
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 105
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 106
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 107
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 108
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 109
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 110
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 111
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 112
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 113
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 114
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 115
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 116
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 117
Suggested Citation: "4 Design Considerations: Pregnancy." Institute of Medicine. 2008. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press. doi: 10.17226/12056.
Page 118
Next Chapter: 5 Design Considerations: Adherence
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.